Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
Lexicon Pharmaceuticals, Inc. Cash Flow 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Operating Cash Flow | -67.9M | -178.8M | -161.9M | -88.9M | -87.0M | -143.0M | 113.8M | -148.6M | -185.4M | -175.6M | 184.8M | -75.6M | -91.1M | -94.5M | -87.9M | -82.4M | -89.0M |
| Depreciation & Amort. | 621,000 | 534,000 | 554,000 | 427,000 | 292,000 | 2.9M | 3.7M | 3.7M | 3.4M | 2.1M | 727,000 | 1.9M | 2.9M | 4.2M | 4.9M | 5.4M | 6.2M |
| Investing Activities | |||||||||||||||||
| Capital Expenditure | 0 | 1.0M | 470,000 | 1.3M | 1.2M | 87,000 | 70,000 | 95,000 | 228,000 | 231,000 | 910,000 | 80,000 | 1.7M | 492,000 | 1.2M | 1.1M | 369,000 |
| Free Cash Flow | -67.9M | -179.8M | -162.4M | -90.2M | -88.2M | -143.1M | 113.7M | -148.7M | -185.6M | -175.9M | 183.9M | -75.7M | -92.8M | -95.0M | -89.1M | -83.5M | -89.4M |
| Financing Activities | |||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | 1.7M | 824,000 | 864,000 | 2.7M | 1.0M | 941,000 | 972,000 | 1.7M | 621,000 | 357,000 | 887,000 | 873,000 | 285,000 | 108,000 | 149,000 | 88,000 |
Lexicon Pharmaceuticals, Inc. Cash Flow — FAQ
Lexicon Pharmaceuticals, Inc. (LXRX) cash flow over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LXRX's cash flow history?
The chart and table above show Lexicon Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.